STARSNCT03728478
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion date changed from estimate of Feb 28, 2025 to Oct 31, 2025 Show 6 more changesShow less
- Eligibility criteria expanded, about 8 words
- Trial status changed: Unknown → Active, Not Recruiting
- Study completion pushed from Feb 28, 2025 to Dec 31, 2026
- Secondary endpoints: details revised at 7 of 8 entries
- Site details revised
- Publications: details revised at 4 of 4 entries
- Minor Changed Registry marked status Unknown; last known: Recruiting
- Notable Primary and study completion dates: Feb 28, 2024 to Feb 28, 2025v7
- Notable Primary and study completion dates pushed to Feb 28, 2024
- Study description expanded, about 121 words
- Notable Primary completion date: Mar 2021 to Mar 2022
- Study completion date: Mar 2021 to Jun 2022
Show 2 earlier versionsHide 2 earlier versions
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Mar 2019 to May 29, 2019
- Notable Start date: Dec 2018 to Mar 2019
- Primary completion date: Dec 2020 to Mar 2021
- Study completion date: Dec 2021 to Mar 2021
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Clinical remission on or off medication at 12 months
Timeframe: 12 months
Secondary (8)
Inactive disease
Time to inactive disease as per JADAS/JIA ACR criteria
Time to JADAS/JIA ACR clinical remission
Time spent in JADAS/JIA ACR inactive disease
Cumulative level of disease activity throughout the study period
Show 3 moreShow less
Time spent on therapy
Rate of flares
Rate of uveitis onset
Arms and interventions
Treatment arm 1: Step-upNo intervention
JIA patients managed with a Treat-To-Target strategy (T2T)
Treatment arm 2: Step-downExperimental
JIA patients treated with an early combined therapy
Drugs: Etanercept, Methotrexate, Intra-articular corticosteroid injections
Sites
1 site in 1 country
- IRCCS Istituto Giannina GasliniGenova, GE, Italy